	Identifying druggable proteins of the association of chronotype on breast cancer using Mendelian randomization. Commun Med (Lond) Luo S, Ai Y, Zheng J, Wan EYF, Yoshiji S, Au Yeung SL. PMID: 42323475 [PubMed - as supplied by publisher]
	Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer. NPJ Digit Med Frenel JS, Heudel PE, Guinaudeau E, Bossard C, Pisano C, Caruso G, Rynkiewicz J, Salhi S, Salhi Y, Chetritt J, Pujade-Lauraine E, Ray-Coquard I. PMID: 42323410 [PubMed - as supplied by publisher]
	Deciphering glutamine metabolic reprogramming: a novel therapeutic target ALDH18A1 in triple-negative breast cancer. Sci Rep Li S, Gao S, Hu J, Lyu S, Yang J, Zhang C, You C, Liu X, Wang J, Liu G. PMID: 42323345 [PubMed - as supplied by publisher]
	SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer. Ann Oncol Garrido-Castro AC, Kim SE, Li T, Desrosiers J, Nanda R, Abdou Y, Clark AS, Sacks RL, O'Connor T, Sinclair N, Lo S, Augdahl G, Wrabel E, DiLullo M, Rahman T, Patel A, Hughes ME, Baginska J, Lange PB, O'Meara T, Keenan TE, Gorthi A, D'Ippolito A, Painter CA, Eaton M, Barrett JC, Koca B, Kurnia PT, Perry AN, Tejeda Zanudo JG, He M, Dillon DA, Lin NU, Burstein HJ, Mittendorf EA, Jeselsohn R, Rimm DL, Tayob N, Tolaney SM. PMID: 42323161 [PubMed - as supplied by publisher]
	Immunotherapy Resistance in Triple-Negative Breast Cancer: Mechanisms and Emerging Therapeutic Strategies. Cancer Lett Zhao H, Tian H, Nuerbieke T, Ma K, Li W, Niu X, Li J, Ashby CR, Chen ZS, Zhou T, Li W, Li D. PMID: 42323003 [PubMed - as supplied by publisher]
	Folate receptor-Î± targeted therapies in ovarian cancer: recent advances and emerging therapeutic strategies. Int Immunopharmacol Singh B, Singh D, Sah A, Kumari P, Kumar D, Sharma D. PMID: 42322854 [PubMed - as supplied by publisher]
	Thermal ablation for early-stage breast cancer: cryoablation, microwave ablation, radiofrequency ablation, high-intensity focused ultrasound ablation, and laser ablation - a systematic review. Breast Erdos J, Kern J, Giess D, Drozgyik A, Goetz G. PMID: 42322704 [PubMed - as supplied by publisher]
	Glutathione S-Transferase Mu1 polymorphisms and environmental factors in cervical cancer susceptibility: a systematic review and meta-analysis. Cell Mol Biol (Noisy-le-grand) Ouedraogo TC, Bazie BVEJT, Simporé A, Ouattara AK, Ouedraogo RA, Traoré L, Yelemkouré TE, Kagembega YD, Sama WA, Savadogo M, Sagna T, Zouré AA, Zohoncon TM, Djigma FW, Karou DS, Simporé J. PMID: 42322564 [PubMed - indexed for MEDLINE]
	A novel model for assessing lymph node metastasis and the immune microenvironment in breast cancer by integrating digital pathology images and transcriptomics. Discov Oncol Sha Y, Zhuang H, Wang Y, Guo H, Cheng H. PMID: 42322380 [PubMed - as supplied by publisher]
	Emerging role of plant-based compounds as ferroptosis modulators in breast cancer. Naunyn Schmiedebergs Arch Pharmacol Pandey P, Mallick N, Ali S, Verma M, Lakhanpal S, Sharma S, Khan MM, Khan F. PMID: 42322357 [PubMed - as supplied by publisher]
	Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment. J Drug Target N L, S V, Ibraheam A M MN, Sherin F, Soman S. PMID: 42322195 [PubMed - as supplied by publisher]
	Clinical Characteristics and Prognostic Risk Factors in Breast Cancer With Liver Metastasis. Breast J Yu D, Zhu C, Yang S, Wang D, Guan X. PMID: 42322174 [PubMed - indexed for MEDLINE]
	Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases. Pharm Stat Rabari P, Biswas P, Kersey JX, Samawi H. PMID: 42322020 [PubMed - indexed for MEDLINE]
	Charleson and Elixhauser Comorbidity Indices in Predicting Mortality Among Young and Old Cervical Cancer Patients. Cancer Med Kulkarni A, Wiener HW, Boitano TKL, Szychowski JM, Shrestha S. PMID: 42322013 [PubMed - indexed for MEDLINE]
	Dance and Dietary Intervention Improves Metabolic Health, Fitness, and Quality of Life With Modest Gut Microbiota Shifts in Breast Cancer Patients With Obesity: A Pilot RCT. Cancer Rep (Hoboken) Nechalová L, Penesová A, Hric I, Olej P, , Ugrayová S, Hekkala J, Kel, Grendár M, Pekkala S, Bielik V. PMID: 42321999 [PubMed - indexed for MEDLINE]
	Association of hormone receptor-based pathological features with prognosis in high-grade serous ovarian carcinoma: a retrospective cohort study and nomogram construction. J Ovarian Res Zhu C, Sun H, Luo Y, Ge D, Yao S, Wang Y, Yan M, Lyu Y, Liu J. PMID: 42321891 [PubMed - as supplied by publisher]
	Novel approaches to modulate CAR-T cell function by targeting the tumor microenvironment in ovarian cancer. J Ovarian Res SamadiAfshar S, Azizi H, Yeganeh M, SamadiAfshar S, Skutella T. PMID: 42321853 [PubMed - as supplied by publisher]
	Alternative splicing rewires breast cancer and opens therapeutic avenues. Cell Commun Signal Jin Y, Liang Y, Kasvaei MM, Yang Q. PMID: 42321779 [PubMed - as supplied by publisher]
	FLASH radiotherapy preserves hepatic function and maintains metabolic homeostasis in a murine breast cancer model: an experimental preclinical study. Radiat Oncol Lu X, Xie D, Cui L, Shang H, Zhou L. PMID: 42321761 [PubMed - as supplied by publisher]
	PD-L1 copy number loss is associated with lower survival in women with advanced breast cancer in Indonesian cohort. BMC Cancer Karsono R, Al Azhar M, Utari AD, Perdana AB, Umaya ER. PMID: 42321710 [PubMed - as supplied by publisher]

Articles 1 - 20 / 330476

Page 1 of 16524



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy